The Rise of Patient Support Programs: Opportunities for Pharma
Advanced, well-designed patient support programs (PSP) are central to pharma’s patient centricity agenda and can deliver multiple stakeholder and commercial benefits. But challenges remain. How can you build awareness of your PSP? In what ways is digital technology driving PSP innovation and outcomes? What are the downsides of PSP generated pharmacovigilance data? How can PSPs play into your go-to-market strategy? In this report, experts reveal practical strategies for developing and delivering powerful and productive PSPs.
Companies
Roche, GlaxoSmithKline, AstraZeneca, Sanofi, Merck & Co., Bristol Myers Squibb, Daiichi Sankyo, Microsoft, Deloitte, Patchai
- Subject synopsis
- Research methodology and objectives
- Key insights summary
- Issues and insights
- The evolution of PSPs
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- HCP engagement
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Patient awareness
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Legal and regulatory frameworks
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Pharmacovigilance
- Issue summary
- Questions
- Key insights
- Supporting quotes
- PSPs in a digital world
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Harnessing PSP data
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Measuring PSP impact
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Recipe for success
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
- Future opportunities
- Issue summary
- Questions
- Key insights
- Supporting quotes
- Intelligence exhibits
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook